logo-loader

Advanced Biomed to raise $150M in IPO

Published: 10:31 23 May 2023 EDT

IPO - gold IPO key on keyboard

Advanced Biomed, a Taiwan-based diagnostics developer, is planning to raise up to $150 million in an initial public offering (IPO). 

The company said it intends to list on the Nasdaq under the ticker symbol ‘ADVB’, according to documents filed with the Securities and Exchange Commission (SEC) on Monday.

The IPO is being managed by Univest Securities. Pricing terms for the offering were not disclosed.

Founded in 2014, Advanced Biomed has developed its own microfluidic technology platform and provides products and services to cancer patients, including early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer.

A holding company incorporated in Nevada, it is operated through Advanced Biomed Taiwan, which is responsible for the operation, design and development of the company’s technologies and products, and Advanced Biomed HK Limited, its first localized operation company focused on the Chinese market. 

Contact the author at emily.jarvie@proactiveinvestors.com

Follow her on Twitter @emilyjjarvie

Arrow Exploration CEO on Icaco success, record production and next drilling...

Arrow Exploration Corp (TSX-V:AXL, AIM:AXL, OTC:CSTPF) CEO Marshall Abbott talked with Proactive's Stephen Gunnion about the company's latest drilling success at Icaco in Colombia, where the IC-HZ9 well has exceeded production expectations and helped lift corporate output above 7,000 barrels of...

5 hours, 34 minutes ago